These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 34433042)
1. ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosis. Qian Y; Arellano G; Ifergan I; Lin J; Snowden C; Kim T; Thomas JJ; Law C; Guan T; Balabanov RD; Kaech SM; Miller SD; Choi J Cell Rep; 2021 Aug; 36(8):109602. PubMed ID: 34433042 [TBL] [Abstract][Full Text] [Related]
2. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. Rostami A; Ciric B J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791 [TBL] [Abstract][Full Text] [Related]
3. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway. You Z; Timilshina M; Jeong BS; Chang JH Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA 182 promotes T helper 1 cell by repressing hypoxia induced factor 1 alpha in experimental autoimmune encephalomyelitis. Wan C; Bi W; Lin P; Zhang Y; Tian J; Fang S; Li Z; Wang X; Qu Y; Mu L; Wang J; Kong Q; Wang G; Sun B; Li H Eur J Immunol; 2019 Dec; 49(12):2184-2194. PubMed ID: 31411745 [TBL] [Abstract][Full Text] [Related]
5. Magnolol as STAT3 inhibitor for treating multiple sclerosis by restricting Th17 cells. Chen JY; Tian XY; Wei SS; Xu W; Pan RR; Chen LL; Chen LD; Nan LH; Yao-Lin ; Shan-Deng ; Wang QQ; Ma XQ; Huang MQ Phytomedicine; 2023 Aug; 117():154917. PubMed ID: 37301184 [TBL] [Abstract][Full Text] [Related]
6. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis. Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651 [TBL] [Abstract][Full Text] [Related]
8. Protein translocation and retro-translocation across the endoplasmic reticulum are crucial to inflammatory effector CD4 Pradeep Yeola A; Akbar I; Baillargeon J; Mercy Ignatius Arokia Doss P; Paavilainen VO; Rangachari M Cytokine; 2020 May; 129():154944. PubMed ID: 32146280 [TBL] [Abstract][Full Text] [Related]
9. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700 [TBL] [Abstract][Full Text] [Related]
10. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Lovett-Racke AE; Yang Y; Racke MK Biochim Biophys Acta; 2011 Feb; 1812(2):246-51. PubMed ID: 20600875 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells. Wachowicz K; Hermann-Kleiter N; Meisel M; Siegmund K; Thuille N; Baier G PLoS One; 2014; 9(5):e96401. PubMed ID: 24788550 [TBL] [Abstract][Full Text] [Related]
12. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation. Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304 [TBL] [Abstract][Full Text] [Related]
14. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis. Lee J; Choi J; Lee W; Ko K; Kim S Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735 [TBL] [Abstract][Full Text] [Related]
15. Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation. Gibson SA; Yang W; Yan Z; Liu Y; Rowse AL; Weinmann AS; Qin H; Benveniste EN J Immunol; 2017 Jun; 198(11):4244-4254. PubMed ID: 28468969 [TBL] [Abstract][Full Text] [Related]
16. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments. Luchtman DW; Ellwardt E; Larochelle C; Zipp F Cytokine Growth Factor Rev; 2014 Aug; 25(4):403-13. PubMed ID: 25153998 [TBL] [Abstract][Full Text] [Related]
17. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region. Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis. Yang C; He D; Yin C; Tan J Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis. Liu Y; Holdbrooks AT; De Sarno P; Rowse AL; Yanagisawa LL; McFarland BC; Harrington LE; Raman C; Sabbaj S; Benveniste EN; Qin H J Immunol; 2014 Jan; 192(1):59-72. PubMed ID: 24323580 [TBL] [Abstract][Full Text] [Related]
20. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Murphy AC; Lalor SJ; Lynch MA; Mills KH Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]